EAM
EFG Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-41,844
| Closed | -$2.94M | – | 180 |
|
|
2024
Q3 | $2.94M | Sell |
41,844
-35,646
| -46% | -$2.51M | 0.49% | 73 |
|
|
2024
Q2 | $6.38M | Buy |
77,490
+355
| +0.5% | +$29.2K | 1.11% | 14 |
|
|
2024
Q1 | $6.74M | Buy |
77,135
+7,519
| +11% | +$657K | 1.16% | 11 |
|
|
2023
Q4 | $6.71M | Buy |
69,616
+2,294
| +3% | +$221K | 1.27% | 10 |
|
|
2023
Q3 | $5.96M | Buy |
67,322
+20,874
| +45% | +$1.85M | 1.41% | 6 |
|
|
2023
Q2 | $4.03M | Buy |
46,448
+35,840
| +338% | +$3.11M | 0.86% | 43 |
|
|
2023
Q1 | $1.03M | Buy |
10,608
+484
| +5% | +$47.1K | 0.23% | 149 |
|
|
2022
Q4 | $1.04M | Sell |
10,124
-197
| -2% | -$20.2K | 0.23% | 147 |
|
|
2022
Q3 | $875K | Buy |
+10,321
| New | +$875K | 0.2% | 153 |
|